x
Filter:
Filters applied
- Glycobiology and Extracellular Matrices
- Day, Anthony JRemove Day, Anthony J filter
- proteoglycanRemove proteoglycan filter
Publication Date
Please choose a date range between 2016 and 2020.
Glycobiology and Extracellular Matrices
2 Results
- Glycobiology and Extracellular MatricesOpen Access
Inter-α-inhibitor heavy chain-1 has an integrin-like 3D structure mediating immune regulatory activities and matrix stabilization during ovulation
Journal of Biological ChemistryVol. 295Issue 16p5278–5291Published online: March 6, 2020- David C. Briggs
- Alexander W.W. Langford-Smith
- Holly L. Birchenough
- Thomas A. Jowitt
- Cay M. Kielty
- Jan J. Enghild
- and others
Cited in Scopus: 9Inter-α-inhibitor is a proteoglycan essential for mammalian reproduction and also plays a less well-characterized role in inflammation. It comprises two homologous “heavy chains” (HC1 and HC2) covalently attached to chondroitin sulfate on the bikunin core protein. Before ovulation, HCs are transferred onto the polysaccharide hyaluronan (HA) to form covalent HC·HA complexes, thereby stabilizing an extracellular matrix around the oocyte required for fertilization. Additionally, such complexes form during inflammatory processes and mediate leukocyte adhesion in the synovial fluids of arthritis patients and protect against sepsis. - Glycobiology and Extracellular MatricesOpen Access
Tumor Necrosis Factor-stimulated Gene-6 (TSG-6) Is Constitutively Expressed in Adult Central Nervous System (CNS) and Associated with Astrocyte-mediated Glial Scar Formation following Spinal Cord Injury
Journal of Biological ChemistryVol. 291Issue 38p19939–19952Published online: July 19, 2016- Vivien J. Coulson-Thomas
- Mark E. Lauer
- Sara Soleman
- Chao Zhao
- Vincent C. Hascall
- Anthony J. Day
- and others
Cited in Scopus: 46Tumor necrosis factor (TNF)-stimulated gene-6 (TSG-6) binds to hyaluronan and can reorganize/stabilize its structure, also enhancing the binding of this glycosaminoglycan to its cell surface receptor, CD44. TSG-6 is rapidly up-regulated in response to inflammatory cytokines protecting tissues from the damaging effects of inflammation. Despite TSG-6 treatment having been shown to improve outcomes in an experimental model of traumatic brain injury, TSG-6 expression has not been extensively studied in the central nervous system (CNS).